skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Deposition, retention, and biological fate of inhaled benzo(a)pyrene adsorbed onto ultrafine particles and as a pure aerosol

Journal Article · · Toxicol. Appl. Pharmacol.; (United States)

The effect of ultrafine, airborne, carrier particles on the deposition, retention, and biological fate of inhaled polycyclic aromatic hydrocarbons (PAHs) was studied. Using a radiolabeled model PAH, (/sup 3/H)benzo(a)pyrene ((/sup 3/H)BaP), Fischer-344 rats were exposed by nose-only inhalation (30 min) to this compound, as a coating (15% by mass) on insoluble /sup 67/Ga/sub 2/O/sub 3/ particles or as a pure aerosol. These aerosols were produced by vapor condensation methods in a dynamic aerosol generation system. The concentrations of (/sup 3/H)BaP in the coated and homogeneous aerosols were 0.6 and 1.0 ..mu..g/liter of air, respectively, while the mass median diameter of both these aerosols was approximately 0.1 ..mu..m. Pulmonary retention of /sup 3/H radioactivity was longer in animals exposed to the (/sup 3/H)BaP coated on the /sup 67/Ga/sub 2/O/sub 3/ particles. The time required to clear 90% of the initial lung burden of /sup 67/Ga/sub 2/O/sub 3/-associated /sup 3/H radioactivity detected 30 min postexposure was approximately 1 day as compared to 4 hr for animals ex Tracheal clearance of 90% of the /sup 67/Ga/sub 2/O/sub 3/-associated /sup 3/H radioactivity required 1 day, while only 1.5 hr were required to clear the same percentage of /sup 3/H radioactivity from the tracheas of rats exposed to the pure (/sup 3/H)BaP aerosol. The rates of clearance of this /sup 3/H material to other tissues suggested that a substantial amount of the (/sup 3/H)BaP coated on /sup 67/Ga/sub 2/O/sub 3/ was cleared from lungs by mucociliary clearance and subsequent ingestion, whereas the majority of the pure (/sup 3/H)BaP aerosol was cleared by direct absorption into blood. In both cases, the ultimate fate of the majority of the (/sup 3/H)BaP and its metabolites was excretion in feces.

Research Organization:
Lovelace Biomedical and Environmental Research Inst., Albuquerque, NM
DOE Contract Number:
AC04-76EV01013
OSTI ID:
6094594
Journal Information:
Toxicol. Appl. Pharmacol.; (United States), Vol. 65
Country of Publication:
United States
Language:
English